Precision biomarkers

Despite good medical standards, diagnostic procedures for the detection of many diseases are insufficiently up-to-date, as current methods are labor-intensive and time-intensive and provide inadequate sensitivity and specificity. The latest advancements in the field of molecular biology could help overcome these problems.

To this end, we exploit the power of next-generation sequencing in our group for the identification of novel biomarkers enabling better diagnosis of diseases such as prostate cancer, COPD or infectious diseases.